F Rovelli

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Robert Altman, L Carreras, Rubén Sierra Díaz et al. · Oxford University Research Archive (ORA) (University of Oxford) · 1994 · 3.3K citations

Thrombosis, Ischemic Stroke, Cardiovascular Disease +9

Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results.

Aldo P. Maggioni, G Zuanetti, MariaGrazia Franzosi et al. · Circulation · 1993 · 364 citations · Full text

Ten-Year Follow-Up of the First Megatrial Testing Thrombolytic Therapy in Patients With Acute Myocardial Infarction

Maria Grazia Franzosi, Eugenio Santoro, Claudio De Vita et al. · Circulation · 1998 · 179 citations · Full text

Prognostic significance of the extent of myocardial injury in acute myocardial infarction treated by streptokinase (the GISSI trial)

Francesco Mauri, Maurizio Gasparini, Lorella Barbonaglia et al. · The American Journal of Cardiology · 1989 · 113 citations · Full text

Gissi Trial, Thrombosis, Cardiogenic Shock +9

EFFECTIVENESS OF LOW-DOSE HEPARIN IN PREVENTION OF MYOCARDIAL REINFARCTION

Gian Gastone Neri Serneri, Gianfranco Gensini, M Carnovali et al. · The Lancet · 1987 · 92 citations

Thrombosis, Cardiovascular Disease, Pharmacotherapy +6